Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents.
about
Imaging poliovirus entry in live cellsAminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunitInhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetineIon-channel modulators: more diversity than previously thoughtKCNE1 and KCNE2 inhibit forward trafficking of homomeric N-type voltage-gated potassium channelsKCNE1 and KCNE2 provide a checkpoint governing voltage-gated potassium channel α-subunit compositionHeterogeneous intrinsic excitability of murine spiral ganglion neurons is determined by Kv1 and HCN channels.Complex distribution patterns of voltage-gated calcium channel α-subunits in the spiral ganglion.Modulation by K+ channels of action potential-evoked intracellular Ca2+ concentration rises in rat cerebellar basket cell axons.Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum.The Kv channel blocker 4-aminopyridine enhances Ag+ uptake: a scanning electrochemical microscopy study of single living cells.Characterization of voltage-gated potassium channels in human neural progenitor cellsPredominant functional expression of Kv1.3 by activated microglia of the hippocampus after Status epilepticus.Aging increases capacitance and spontaneous transient outward current amplitude of smooth muscle cells from murine superior epigastric arteries.Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversyNew approach to measure cutaneous microvascular function: an improved test of NO-mediated vasodilation by thermal hyperemia.Systemic administration of anti-NGF increases A-type potassium currents and decreases pancreatic nociceptor excitability in a rat model of chronic pancreatitis.Optical mapping of release properties in synapses.Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.Chronic deficit in the expression of voltage-gated potassium channel Kv3.4 subunit in the hippocampus of pilocarpine-treated epileptic ratsFrom a pump to a pore: how palytoxin opens the gates.No independent, but an interactive, role of calcium-activated potassium channels in human cutaneous active vasodilation.Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetineLocalization and function of Ih channels in a small neural network.A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons.Elevated synaptic activity preconditions neurons against an in vitro model of ischemiaMechanisms involved in the vasorelaxant effects produced by the acute application of amfepramone in vitro to rat aortic ringsIncreased Kv1 channel expression may contribute to decreased sIPSC frequency following chronic inhibition of NR2B-containing NMDAR.Pathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells.Cellular mechanisms involved in CO(2) and acid signaling in chemosensitive neurons.Cyproheptadine enhances the I(K) of mouse cortical neurons through sigma-1 receptor-mediated intracellular signal pathway.Effects of fluoxetine on protein expression of potassium ion channels in the brain of chronic mild stress rats.Pharmacological characterization of mechanisms involved in the vasorelaxation produced by rosuvastatin in aortic rings from rats with a cafeteria-style diet.Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism.Electrophysiology properties of voltage-gated potassium channels in rat peritoneal macrophagesThe modulation of voltage-gated potassium channels by anisotonicity in trigeminal ganglion neurons.Effects of hydrogen peroxide on voltage-dependent K(+) currents in human cardiac fibroblasts through protein kinase pathwaysDecreased A-currents in hippocampal dentate granule cells after seizure-inducing hypoxia in the immature rat.Pharmacological study of the mechanisms involved in the vasodilator effect produced by the acute application of triiodothyronine to rat aortic ringsAllosteric binding site in a Cys-loop receptor ligand-binding domain unveiled in the crystal structure of ELIC in complex with chlorpromazine
P2860
Q21092757-B6AD7DEF-CD2F-4B5D-8BEC-DB14FF5A36C5Q24657140-22CA3AC2-CE9A-4D17-BDD6-F8B565F42454Q24670560-0B9F1CA4-AA07-427A-9C19-B72B62420B37Q28242282-5BC857F3-BC50-4ED5-B6E4-97CD44579BF6Q28248951-ABF57ABB-2997-4709-9132-B4A6DBB27EE3Q28248961-F78D83FF-BE33-4C16-821D-638835250184Q30420663-DFD157D4-58D8-4D99-B21A-484A57B4276AQ30465165-159869B3-E276-4002-9CA9-3CABDA2919C8Q30789432-63AAD066-38FD-45AD-8624-E579DD169718Q33199898-EEA3E8F8-BEDC-4C42-A191-32D80834A054Q33362306-C9354D69-FB40-41F9-A957-CDD03B78D6D2Q33479532-46F5621A-3A26-48F0-8E71-4CEC0B9E8DCCQ33496717-83558F62-32C0-4910-880F-D397B1F0E260Q33701962-EBF494EE-7902-4DF7-A274-F02EA8823966Q33827991-6361A45B-6FCF-4009-8438-7EC303F68397Q34006296-42C04942-0EE8-40D2-B36D-7BB531748C40Q34061917-08E19423-C7E1-46ED-BE04-1D10DA97863EQ34085810-48FAE60A-3C18-4B58-8498-E6C2285E5859Q34099069-285442E5-C450-4DBB-90CE-E32709DC34A9Q34459275-EAD503D6-D447-485E-B01D-CB6C1E65FDEDQ34469407-0039ABC8-F077-4382-B74E-00D75EEE64D8Q34967538-DD182E60-40C0-4C13-94C3-682733228840Q35041767-26F9167F-7F66-47EB-BAB7-BB2931BEF95DQ35086524-B5D80DE3-AC8C-47FA-BA40-6F68945EA7E5Q35118431-1E3C5E6C-3AEF-4011-8628-1513F7D59E5BQ35676898-8790DD20-E9FC-410A-81FE-AB1B3913E2B7Q35750859-07AE18C7-901A-4E1B-9921-6CD40A9AD527Q35892703-CD654C58-E6C2-4239-B73A-99C452D33E84Q35894504-E8563F47-B331-452E-87F2-6D80B55E4E06Q35938786-0C26CC59-BA71-463F-8933-EE69A0D40371Q36109758-E078F626-5844-4F7E-ABBE-946AD494DA3BQ36237885-FB0305CA-BE16-4293-8A8D-C7FCAD2D5D03Q36302505-C0DAACE1-FD4E-4CEE-A94B-C800D167E882Q36506756-A783EA74-9651-4DE8-8D00-3C6222197088Q36720998-13DBE6CD-D58D-42B7-BB10-37B537DF825EQ36839207-B1B35EA4-79C0-4C4C-9FBF-BAEBF4DBED08Q36881236-064B10DA-6250-4C73-9006-06D2BAF21B52Q36990433-8D1E7BA8-9A5A-4B70-B021-A27201C23EA5Q37135601-D9647359-4BDE-4ED3-B8F9-B28F7D6C0C9CQ37379919-9CDFEB6A-0ECC-491C-81A1-C42A5EFE06B2
P2860
Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Voltage-activated potassium ch ...... novel pharmacological agents.
@en
type
label
Voltage-activated potassium ch ...... novel pharmacological agents.
@en
prefLabel
Voltage-activated potassium ch ...... novel pharmacological agents.
@en
P2093
P50
P1433
P1476
Voltage-activated potassium ch ...... y novel pharmacological agents
@en
P2093
Watkins CS
Wooltorton JR
P356
10.1016/S0306-3623(97)00034-7
P577
1998-01-01T00:00:00Z